The Company continues to deliver on its mission of bringing the benefits of Minimal Access Surgery (MAS) to more patients globally. The Versius® Surgical Robotic System has now been used…
LightForce Orthodontics will expand its manufacturing capabilities to advance production and further its custom orthodontic treatments using AI and 3D printing. BURLINGTON, MA — August 2, 2023 — LightForce Orthodontics,…
Additional financing strengthens Ceribell’s shareholder base and provides capital to support commercial expansion and further development of the company’s first-of-its kind Ceribell Rapid Response EEG System SUNNYVALE, Calif., September 21,…
Ally Bridge Group joins existing syndicate of KCK MedTech, Questa Capital and OrbiMed. Sunnyvale, CA – June 16, 2022 – Aerin Medical Inc., a company dedicated to providing Ear, Nose…
New York, NY—J. Tomilson Hill, Chair, and Wendy Fisher, President, Solomon R. Guggenheim Foundation, today announced that Frank Yu has been elected to the Board of Trustees. In a joint…
Investors say industry’s fundamentals remain strong. By Brian Gormley (WWW.WSJ.COM)–Initial public offerings by biotechnology companies are slowing after two record-setting years as the poor performance of some recent IPOs combined with economic and geopolitical uncertain-ties have cooled interest…
Three oncology and fibrotic disease programs in clinical development by end of 2022 SAN DIEGO (BUSINESS WIRE) — Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal…
Led by Kinnevik and Human Capital and joined by Ally Bridge Group, General Catalyst, 7wireVentures and existing Transcarent investors Leading health systems Northwell Health, Intermountain Healthcare, and Rush University Medical…
The most extensive toolbox of proprietary genomic editors in the industry to enable development of curative, next-generation genetic medicines Co-founded by David Walt, Ph.D. and Feng Zhang, Ph.D. CAMBRIDGE, Massachusetts…
Financing accelerates the growth of Shoreline’s pipeline of iPSC-based cell immunotherapies for the treatment of seriously ill patients and enables the buildout of smart manufacturing capabilities SAN DIEGO, Nov. 2, 2021 /PRNewswire/…
